Zimmer Biomet Announces First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Zimmer Biomet (ZBH) PT Lowered to $130 at RBC Capital
April 27, 2018 9:02 AM EDTRBC Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $140.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company
April 27, 2018 6:28 AM EDTNeedham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "ZBH's 1Q18 revenue and EPS beat consensus. Management's 2018 revenue guidance was above consensus while its EPS guidance was slightly below... More
Zimmer Biomet (ZBH) PT Lowered to $130 at Jefferies; 'Putting in the Bottom?'
April 26, 2018 1:44 PM EDTJefferies lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $141.00) while maintaining a Buy rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'
April 26, 2018 1:17 PM EDTBMO Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $137.00 (from $144.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Raised to $117.50 at Evercore ISI
April 26, 2018 1:05 PM EDTEvercore ISI raised its price target on Zimmer Biomet (NYSE: ZBH) to $117.50 (from $115.00) while maintaining a In Line rating.
What analsyt Vijay Kumar liked:
Management is confident on the supply recovery turnaround in July that will help accelerate sales growth... More